Barinthus Biotherapeutics

Barinthus Biotherapeutics is a clinicalstage biopharmaceutical company focused on developing novel immunotherapies that guide the bodys T cells to treat chronic infectious diseases, autoimmune diseases, and inflammatory conditions. The firm leverages its proprietary platforms to create antigenspecific immunotherapeutic candidates designed to restor... e immune balance, suppress inappropriate immune responses, or stimulate targeted immunity against disease. Originally spun out of university and researchinstitution work, Barinthus has evolved beyond traditional vaccines and now emphasizes Tcell immunotherapy for conditions such as chronic viral infections, autoimmune disorders, and cancer. The companys mission centers on improving patient outcomes by using advanced immunology research to offer potentially transformative therapiesRead More